RCM Technologies, Inc. (NASDAQ: RCMT) reported fourth‑quarter and full‑year 2025 financial results for the 14‑week period ended January 3, 2026. Revenue rose 12.4 % to $86.5 million, while GAAP net income climbed to $6.1 million, or $0.80 per diluted share, compared with $2.9 million, or $0.37 per diluted share, in the prior quarter. Adjusted EBITDA for the quarter reached $9.3 million, a 49.0 % increase from $6.3 million in the same period last year.
Full‑year 2025 revenue totaled $319.4 million, up 14.7 % from $278.4 million in 2024. GAAP net income for the year was $16.3 million, or $2.14 per diluted share, versus $13.3 million, or $1.68 per diluted share, in 2024. Adjusted EBITDA for the year reached $30.7 million, an 18.9 % rise from $25.9 million in the prior year.
The company attributes the growth to sustained demand across its three‑segment model—Specialty Healthcare, Engineering, and Life Sciences/Data—while noting that self‑insured medical costs added a $1.8 million drag to SG&A this year. Gross profit increased to $24.3 million from $21.6 million, reflecting both higher revenue and modest margin expansion. The 49 % jump in adjusted EBITDA and the 18.9 % rise in full‑year adjusted EBITDA demonstrate effective cost management and pricing power amid a favorable mix of high‑margin contracts.
RCM continues a $50 million share repurchase program, buying back shares in late 2025, signaling management confidence in the company’s valuation and cash‑flow generation. The company remains in compliance with its revolving credit facility, with $24.7 million borrowed and $27.1 million available, underscoring a solid liquidity position.
Compared with the fourth quarter of 2024, when GAAP net income fell 45.4 % to $1.6 million and adjusted EBITDA declined, the current quarter’s results represent a sharp turnaround. The year‑over‑year revenue growth of 14.7 % and the increase in profitability metrics illustrate a resurgent operating performance.
RCM will not hold a conference call to discuss the results and directs investors to its Form 10‑K for detailed financial information.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.